Funding
The ASCOT trial is supported by funding from:
Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE)
BHP Foundation
Health Research Council of New Zealand
Hospital Research Foundation
Macquarie Group Foundation
Minderoo Foundation
NSW Health
Pratt Foundation
Royal Brisbane and Women’s Hospital Foundation
The Common Good (The Prince Charles Hospital Foundation)
Wesley Medical Research
Chong Kun Dang Pharmaceutical Corporation
NSW Office for Health and Medical Research
Medical Research Future Fund
The Russell and Womersley Foundation.